Hovan Ramps Up Market Neutral Fund Team

Feb 6 2008 | 8:44am ET

Hovan Capital Management, a San Francisco-based healthcare focused long/short fund, has hired Ajim Tamboli as a senior portfolio manager of the HCM Market Neutral Fund. Tamboli previously served as a senior small biotechnology analyst at Lehman Brothers in San Francisco.

In addition, Lisa Lee-Hwong, previously with SAC Capital Advisors, has joined the firm to support Tamboli as a portfolio manager focused on emerging science. Current HCM analyst Mikael van Loon will be promoted to the role of portfolio manager in charge of top-down quantitative portfolio risk management.

“Ajim’s experience and interaction with the management teams of portfolio companies coupled with Dr. Lee-Hwong’s scientific research experience will provide a strong positive environment in HCM’s public equity healthcare research department,” said Kurt Hovan, president and CIO of HCM.

“Mikael has mastered HCM’s short portfolio quantitative process and is ready to assume the role of portfolio manager in the fund.”

Hovan Capital Management was established in September 1998.


In Depth

Direct Lending: What’s Different Now?

Mar 14 2017 | 8:43pm ET

Senior direct lending funds have become riskier over the past four years, with leverage...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

SEI: Private Debt Coming Into Its Own

Mar 8 2017 | 9:24pm ET

The explosive growth of private debt over the past few years has caused the lines...

 

From the current issue of